Universal Health International Group Holding (HKSE:02211) Cash Flow for Dividends: HK$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02211 Universal Health International Group Holding Ltd HKSE:02211
37 GF Score
Price HK$0.66
GF Value HK$0.29
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Universal Health International Group Holding Cash Flow for Dividends?

Universal Health International Group Holding HKSE:02211 -7.75% 37 Cash Flow for Dividends is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:02211 with a GF Score™ of 37/100 and a GF Value™ of HK$0.29 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Universal Health International Group Holding's cash flow for dividends for the six months ended in Dec. 2025 was HK$0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Universal Health International Group Holding Cash Flow for Dividends Related Terms

Universal Health International Group Holding Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Universal Health International Group Holding's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Health International Group Holding Cash Flow for Dividends Chart

Universal Health International Group Holding Annual Data
Trend Dec14 Dec15 Dec16 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Universal Health International Group Holding Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:02211
37GF Score
Universal Health International Group Holding Ltd HKSE:02211
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universal Health International Group Holding Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of HK$0.0 Mil mean?
Universal Health International Group Holding (HKSE:02211) has a Cash Flow for Dividends of HK$0.0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Universal Health International Group Holding and its competitors.
Is Universal Health International Group Holding's Cash Flow for Dividends too high?
Universal Health International Group Holding's current Cash Flow for Dividends is HK$0.0 Mil. Overall, Universal Health International Group Holding has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universal Health International Group Holding's Cash Flow for Dividends compare to competitors?
Universal Health International Group Holding's Cash Flow for Dividends of HK$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Universal Health International Group Holding and its competitors. Universal Health International Group Holding's current Cash Flow for Dividends is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Health International Group Holding stock overvalued right now?
Based on GuruFocus' analysis, Universal Health International Group Holding (HKSE:02211) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.29, compared to a current price of HK$0.66 — trading 125.9% above its estimated fair value. The current Cash Flow for Dividends is HK$0.0 Mil. Universal Health International Group Holding's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Universal Health International Group Holding (HKSE:02211), the current Cash Flow for Dividends is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universal Health International Group Holding (HKSE:02211) Overvalued in 2026?

Based on GuruFocus' analysis, Universal Health International Group Holding stock appears to be overvalued. The current stock price of HK$0.66 is trading 125.9% above its estimated GF Value™ of HK$0.29. GuruFocus considers Universal Health International Group Holding to be Significantly Overvalued.

Key valuation signals for HKSE:02211:

  • Cash Flow for Dividends: HK$0.0 Mil
  • GF Value™: HK$0.29 vs. price of HK$0.66 (125.9% above fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02211 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universal Health International Group Holding Business Description

Address No. 14-1, Bei Yi Zhong Road, Tiexi District, Liaoning Province, Shenyang, CHN
Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. The company operates its business through two segments: pharmaceutical retail and Distribution, (including import and export trade) include prescribed drugs, non-prescribed drugs (Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs), traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, etc. and majority of revnue comes from Distribution segment.
37GF Score

Get the complete analysis for HKSE:02211

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.66
Price
HK$0.29
GF Value